查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886288

臨床試驗影像市場－全球產業規模、佔有率、趨勢、機會和預測，依產品和服務、影像方式、最終用戶、地區和競爭格局分類，2020-2030年預測

Clinical Trial Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Service, By Modality, By End-User, By Region, By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球臨床試驗影像市場規模為11.8億美元，預計2030年將以7.30%的複合年成長率成長至18億美元。臨床試驗影像市場涵蓋了磁振造影、電腦斷層掃描和正子斷層掃描等醫學影像技術的應用，旨在客觀評估臨床開發過程中試驗性療法的安全性和有效性。

市場概覽
預測期 2026-2030
市場規模：2024年 11.8億美元
市場規模：2030年 18億美元
複合年成長率：2025-2030年 7.30%
成長最快的細分市場 電腦斷層掃描
最大的市場 北美洲

主要市場促進因素

隨著製藥和生物技術公司不斷拓展治療產品線，全球臨床試驗數量的持續成長是推動臨床試驗影像市場發展的關鍵因素。這種擴張需要對藥物安全性和有效性進行全面的影像評估，從而直接增加了對專業服務的需求。

主要市場挑戰

影像設備所需的大量資本支出直接阻礙了全球臨床試驗影像市場的成長。購置和維護先進醫學影像設備（例如磁振造影或正子斷層掃描系統）的高昂成本，給臨床試驗中心和合約研究組織帶來了沉重的經濟負擔。

主要市場趨勢

分散式和混合式臨床試驗模式的採用，從根本上重塑了全球臨床試驗影像市場的營運策略，提高了病患就診便利性，簡化了資料收集流程。這種方法整合了遠距醫療和穿戴式裝置等遠距技術，減少了患者現場就診的需求，從而擴大了受試者招募的地域範圍。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球臨床試驗影像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品及服務分類（試驗設計諮詢服務、讀取分析服務、手術影像服務、影像軟體）
    • 依檢查方式分類（磁振造影、電腦斷層掃描、超音波、正子斷層掃描、X光、超音波心動圖、其他檢查方式）
    • 按最終用戶（製藥和生物技術公司、醫療器材製造商、學術和政府研究機構）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美臨床試驗影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲臨床試驗影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區臨床試驗影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲臨床試驗影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲臨床試驗影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球臨床試驗影像市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Clario Medical Imaging Inc
  • Icon PLC
  • Ixico PLC
  • Koninklijke Philips NV
  • Medpace
  • Navitas Clinical Research, Inc
  • Parexel International Corporation
  • ProScan Imaging
  • Radiant Sage LLC
  • Resonance Health

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22206

The Global Clinical Trial Imaging Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 7.30% to reach USD 1.80 Billion by 2030. The clinical trial imaging market encompasses the application of medical imaging modalities, such as Magnetic Resonance Imaging, Computed Tomography, and Positron Emission Tomography, to objectively assess the safety and efficacy of investigational therapeutics throughout clinical development.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.18 Billion
Market Size 2030USD 1.80 Billion
CAGR 2025-20307.30%
Fastest Growing SegmentComputed Tomography
Largest MarketNorth America

Key Market Drivers

The increasing global clinical trial volume is a fundamental driver for the clinical trial imaging market as pharmaceutical and biotechnology companies expand therapeutic pipelines. This expansion necessitates comprehensive imaging for drug safety and efficacy assessments, directly increasing demand for specialized services. This growth is evidenced by the rising number of registered studies; according to ClinicalTrials. gov, as of October 10, 2025, the number of registered studies reached 74,339.

Key Market Challenges

The substantial capital expenditure required for imaging equipment directly impedes the growth of the Global Clinical Trial Imaging Market. The high cost of acquiring and maintaining advanced medical imaging modalities, such as Magnetic Resonance Imaging or Positron Emission Tomography systems, places a significant financial burden on clinical trial sites and contract research organizations. This barrier limits the ability of many entities, particularly smaller or emerging research centers, to invest in the latest technology or expand their imaging capabilities.

Key Market Trends

The adoption of decentralized and hybrid clinical trial models is fundamentally reshaping operational strategies within the global clinical trial imaging market by enhancing patient accessibility and streamlining data collection. This approach integrates remote technologies such as telemedicine and wearable devices, reducing the need for extensive on-site patient visits and thereby broadening the geographic reach for participant recruitment. TransCelerate BioPharma's 2024 Annual Report indicates that both mature and newer initiatives have achieved 75% or higher adoption rates among their member companies in recent years, reflecting the increasing integration of flexible trial designs.

Key Market Players

  • Clario Medical Imaging Inc
  • Icon PLC
  • Ixico PLC
  • Koninklijke Philips N.V
  • Medpace
  • Navitas Clinical Research, Inc
  • Parexel International Corporation
  • ProScan Imaging
  • Radiant Sage LLC
  • Resonance Health

Report Scope:

In this report, the Global Clinical Trial Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Imaging Market, By Product and Service:

  • Trial Design Consulting Services
  • Read Analysis Services
  • Operational Imaging Services
  • Imaging Software

Clinical Trial Imaging Market, By Modality:

  • Magnetic Resonance Imaging
  • Computed Tomography
  • Ultrasound
  • Positron Emission Tomography
  • X-Ray
  • Echocardiography
  • Other Modalities

Clinical Trial Imaging Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic and Government Research Institute

Clinical Trial Imaging Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Trial Imaging Market.

Available Customizations:

Global Clinical Trial Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Trial Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software)
    • 5.2.2. By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities)
    • 5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic and Government Research Institute)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Clinical Trial Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Service
    • 6.2.2. By Modality
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Trial Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product and Service
        • 6.3.1.2.2. By Modality
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Clinical Trial Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product and Service
        • 6.3.2.2.2. By Modality
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Clinical Trial Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product and Service
        • 6.3.3.2.2. By Modality
        • 6.3.3.2.3. By End User

7. Europe Clinical Trial Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Modality
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Clinical Trial Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Modality
        • 7.3.1.2.3. By End User
    • 7.3.2. France Clinical Trial Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Modality
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Clinical Trial Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Modality
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Clinical Trial Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Modality
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Clinical Trial Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Modality
        • 7.3.5.2.3. By End User

8. Asia Pacific Clinical Trial Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Modality
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Clinical Trial Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Modality
        • 8.3.1.2.3. By End User
    • 8.3.2. India Clinical Trial Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Modality
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Clinical Trial Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Modality
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Clinical Trial Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Modality
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Clinical Trial Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Modality
        • 8.3.5.2.3. By End User

9. Middle East & Africa Clinical Trial Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Modality
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Clinical Trial Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Modality
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Clinical Trial Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Modality
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Clinical Trial Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Modality
        • 9.3.3.2.3. By End User

10. South America Clinical Trial Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Modality
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Trial Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Modality
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Clinical Trial Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Modality
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Clinical Trial Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Modality
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Clinical Trial Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Clario Medical Imaging Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Icon PLC
  • 15.3. Ixico PLC
  • 15.4. Koninklijke Philips N.V
  • 15.5. Medpace
  • 15.6. Navitas Clinical Research, Inc
  • 15.7. Parexel International Corporation
  • 15.8. ProScan Imaging
  • 15.9. Radiant Sage LLC
  • 15.10. Resonance Health

16. Strategic Recommendations

17. About Us & Disclaimer